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Abstract 
The treatment of UDP-glucuronosyltransferase UGTI*6 stably expressed inV79 cells with three carboxyl-specific reagents, dicyclohexylcarbodiim- 
ide, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N- thyl-5-phenylisoxazolium-3'-sulfonate (Woodward's reagent K), resulted in a fast, 
dose-dependent decrease of the 4-methylumbelliferone glucuronidation. The inactivation reactions followed pseudo-first order kinetics. The pKa of 
the modified residue was close to 5.0. A partial protection against inactivation by Woodward's reagent was observed at pH 7.4 in the presence of 
UDP-glucuronic acid, UDP, and, to a lesser extent, in the presence of 4-methylumbelliferone. Dicyclohexylcarbodiimide significantly decreased the 
V~, without affecting the apparent K~ towards UDP-glucuronic acid and 4-methylumbelliferone. Theresults upport he involvement ofa carboxyl 
group in the catalytic process. 
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1. Introduction 
UDP-glucuronosyltransferases (EC 2.4.1.17; UGT) 
represent a superfamily of enzymes which catalyze the 
conjugation of glucuronic acid from UDP-glucuronic 
acid (UDP-GlcU) to a variety of structurally unrelated 
compounds which possess ahydroxyl, carboxyl, sulfhyd- 
ryl or amino group [1]. Drugs or endogenous compounds 
that are important for cell differentiation and growth 
(e.g. steroid and thyroid hormones, fatty acids, retinoic 
acid) are substrates of these enzymes [2,3]. The glucu- 
ronides formed are generally inactive metabolites and 
are excreted into urine or bile [4]. However, some glucu- 
ronides, such as the acylglucuronides formed from car- 
boxylic acid-containing drugs or N-hydroxyglucuronides 
from arylamines are known for their unstability and re- 
activity, responsible for toxicity reactions in man [5,6]. 
In order to elucidate the molecular basis of the formation 
of the glucuronides, we have expressed the human liver 
UGTI*61 isoform in recombinant V79 cells [7]. This en- 
zyme is involved in the glucuronidation of planar and 
short phenolic substances ( uch as 4-methylumbellifer- 
one, 4-MU), including the drug paracetamol [8-10]. In 
an attempt to investigate he key amino acids which play 
a role in catalysis, we recently demonstrated, by chemical 
modification of the protein with diethylpyrocarbonate, 
the involvement of an histidine residue in the glucu- 
ronidation process [11]. Moreover, from the pH profile 
of the VmaxlK m data of the enzyme, a possible implication 
of a carboxylic acid in catalysis was postulated. In the 
present study, such hypothesis was evaluated by the 
mean of three carboxyl-specific reagents. Our results 
clearly support he participation of such a residue in the 
catalytic process of UGTI*6. 
2. Materials and methods 
Dicyclohexylcarbodiimide and 1-ethyl-3-(3-dimethylaminopropyl)- 
carbodiimide were purchased from Aldrich (Saint-Quentin-Fallavier, 
France); N-ethyl-5-phenylisoxazolium-Y-sulfonate (Woodward's rea- 
gent K, WK reagent) and UDP were obtained from Sigma (St. Louis, 
MO). UDP-GIcU was from Boehringer (Mannheim, Germany). All 
other chemicals were of the best purity commercially availble. 
*Corresponding author. Fax: (33) 83 32 13 22. 
Abbreviations: UGT, UDP-glucuronosyltransferase; UDP-GlcU, 
UDP- glucuronic acid; 4-MU, 4-methylumbelliferone; DCC, dicyclo- 
hexylcarbodiimide; EDC, 1-ethyl-3-(3-dimethylaminopropyl)-car- 
bodiimide; WK reagent, N-ethyl-5-pbenylisoxazolium-Y-sulfonate; 
HPLC, high- performance liquid chromatography. 
1UGTI*6 and UGTI*02 are encoded by two members of family 1 of 
the UGT gene superfamily [1]. The asterisk indicates that these isoforms 
are derived by alternative splicing from a primary transcript common 
to several isoforms encoded by the UGT1 locus. UGT2BI is encoded 
by a gene belonging the subfamily 2B [1]. 
2.1. Cell cultures and preparation of the membrane fractions 
Establishment and culture of V79 cells expressing UGT 1"6 was per- 
formed as previously described [7,11]. Two other V79 cell lines express- 
ing the UGT2B1 and UGTI*02 isoforms were also used. The rat liver 
UGT2B1 catalyzes the glucuronidation of morphine and carboxylic 
acids (fatty acids, nonsteroidal nti-inflammatory drugs) [2]; the human 
liver UGTI*02 glucuronidates bulky phenols [9]. The enriched mem- 
brane fractions were obtained from the cell homogenate by differential 
ultracentrifugation. The homogenate, obtained by a 3 x 10-s sonication 
(Vibra cell 72446, Bioblock, IIIkirch, France) of 100 mg of cells protein 
resuspended in 60 ml of 0.25 M sucrose, 5 mM HEPES (pH 7.4), was 
centrifuged at 10,000 x g for 10 min. The supernatant was then centri- 
fuged at 100,000 x g for 60 rain. The resulting pellet was homogenized 
in 0.25 M sucrose, 5 mM HEPES (pH 7.4) and stored at -20°C. Under 
these conditions, a fully active UGT was associated to this membrane 
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fraction. Attempts to further purify this phospholipid-dependent pro- 
tein [12,13] lead to enzyme inactivation. Protein concentration was 
measured according to Bradford [14], with bovine serum albumin as 
standard 40-60% of the total enzymatic activity was recovered in the 
final membrane fraction. The enrichment interm of specific activity was 
about 1.3-fold, compared to the starting cell homogenate. 
2.2. Inactivation of UGTs by carboxyl,specific reagents 
The membrane fractions were adjusted to 1.3 mg protein/nil with 50 
mM sodium/potassium phosphate buffer (pH 5.0), 5 mM MgCI2, unless 
specified. Dilution of earboxyl-specific reagents were prepared just be- 
fore use. The WK reagent was diluted in 1 mM HCI. The carbodiimide 
derivatives were prepared in dimethyl sulfoxide. Solvents (2% v/v for 
experiments with WK reagent and 5% v/v for experiments with car- 
bodiimide derivatives) were shown not to affect the glucuronidation 
activity. Inactivation experiments, including protection by substrates, 
were performed at 20°C as follows: inactivation was initiated by addi- 
tion of the earboxyl-specific reagents at concentrations ranging from 
0.1 mM to 5.0 mM (depending on the compound used). A control 
experiment performed with the solvent alone was run simultaneously 
and corresponded to 100 percent of activity. The effect of ligands on 
the inactivation of UGTI*6 by 2 mM WK reagent was performed at 
concentrations corresponding to l0 apparent Km (4-ML0 (2.5 mM), l0 
apparent Km (UDP-GIcU) (2.1 mM), and l0 apparent Ki CUDP) (5.9 
raM), at pH 7.4. The chemical modification was stopped at various 
periods of time by a 60-fold dilution of the proteins in 180 mM Tris-HCl 
(pH 7.4), 28 mM MgC12, 5 mM ghitamic acid (buffer 1) and the giucu- 
ronidation activity was determined by a fluorimetric assay with 4-MU 
as substrate; for this purpose, the membrane fractions (3/zg protein) 
were incubated with 4-MU (1 raM) and UDP-GlcU (5 raM) for 25 min 
at 37°C [11], and the reaction was stopped by the addition of 800 gl 
of ice-cold water. Unconjugated 4-MU was then extracted by 4 ml of 
ethyl acetate. Samples were centrifuged and 200 gl of the aqueous phase 
was mixed with 1.8 ml of 0.25 M glycine-NaOH buffer (pH 10.3). The 
fluorescence measurements were performed on a Hitachi F2000 spec- 
trofluorimeter (ScienceTec, Les Ulis, France) at excitation and emission 
wavelengths of 320 and 380 urn, respectively, with authentic 4-methyl- 
umbelliferyl-fl-D-ghicuronide (Sigma) as standard. No addition of de- 
tergent was required for the measurement of the activity since the 
sonication procedure provided a mecanical activation of the mem- 
brane-bound UGT resulting in full activation. The inactivation kinetics 
of UGTl*6 by earboxyl-specific reagents were fitted to equation I.
log (% residual activity) = - k' i - t (I) 
where k~ is the pseudo-first order inactivation rate constant and t the 
time of inactivation for which the residual activity is evaluated. The 
inactivation order (n) was calculated according to equation II
log ki = n.log [inactivator] +log k' i (II) 
with k'~ the second-order inactivation constant. The PKa of the essential 
residue modified by WK reagent was evaluated following the equation 
III, while that of the residue modified by DCC was determined accord- 
ing to the equation IV 
1/k~ = [H*]/km'K, + 1/km (III) 
1/ki = Kff[I-I+]'km + 1~kin (IV) 
where k m is the maximal pseudo-first-order inactivation rate constant 
and Ka the ionization constant of the modified residue• Inactivation 
experiments with increasing concentrations of the nucleophilic om- 
pounds glycine methyl ester and glycine ethyl ester (5--50 raM) were 
carried out with membrane fractions (1.3 mg proteindml) in 50 mM 
sodium/potassium phosphate (pH 5.0), 5 mM MgC12. UGTI*6 inacti- 
vation was performed with DCC at 1 mM for 1 rain following the 
addition of glycine methyl ester or glycine ethyl ester, and compared 
to that observed without he presence of both exogenous nucleophiles. 
2.3. Treatment of UDP-GlcU with WK reagent 
UDP-GIcU (2 mM) was added either to 2 mM WK reagent (2% v/v 
in 1 mM HCI) or to 1 mM HC1 (control) for 3 min in the conditions 
described for the protection experiments, but without membrane frac- 
tions. 50 gl of the incubation medium was injected on a Hibar Lichro- 
sorb RP-18 HPLC column (7/zm) (Merck, Darmstadt, Germany) fol- 
lowing a 60-fold dilution in buffer 1. The mobile phase was composed 
of 50 mM ammonium phosphate/phosphoric acid (pH 3.0) with 2.5% 
methanol (v/v). The retention time of UDP-GIcU was 16.5 rain, upon 
detection at 260 nm with a constant flow rate of 0.4 ml/min. 
3. R ~  
3.1. Effect o f  carboxyl-specific reagents on the UGTI*6  
activity 
The g lucuron idat ion  o f  4 -MU cata lysed by UGTI*6  
was rapid ly  decreased as a funct ion  o f  t ime and  concen-  
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Fig. 1. Inactivation of UGTI*6 enzyme by carboxyl-specific reagents. 
Membrane fractions (1.3 mg proteins/ml) of the recombinant V79 cells 
expressing UGTl*6 were incubated at 20°C in 50 mM sodium/potas- 
sium phosphate buffer, 5 mM MgC12 with inactivators at pH 5.0 (DCC 
and EDC) and pH 6.0 0VK reagent). (A) Inactivation by DCC (o), 
0.1 mM; (e), 0.3 raM; ([]), 0.4 raM; (m), 0.7 mM. (B) Inactivation by 
EDC (o), 2 raM; (o), 4 mM; (D), 5 mM; (m), 8 raM. (C) Inactivation 
by WK reagent (o), 1.0 raM; (e), 1.5 raM; (o)), 2.0 raM; (u), 3.0 raM; 
(A), 5.0 mM. A//I o corresponds to the ratio of the activity in the pres- 
ence of inhibitor, at the time point considered, vs. the initial activity 
without inhibitor. 
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Fig. 2. pH dependence of the inactivation fUGT 1"6 by WK reagent 
and DCC. The membrane fractions were diluted to 1.3 mg proteins/ml 
in 50 mM sodium/potassium phosphate buffer (pH 5.0-7.0), 5 mM 
MgCI2. Inactivation was performed with 0.5 mM DCC (A) and 2.5 mM 
WK reagent (B) at the indicated pHs. 
tration of DCC, EDC and WK reagent. Plotting on a 
semi-logarithmic s ale the residual activity as a function 
of the time of inactivation showed a time and dose de- 
pendent inactivation of the enzyme by DCC, EDC and 
WK reagent (Fig. 1) which indicated that the inactiva- 
tion of the enzyme by each of the reagents followed a 
pseudo-first-order kinetic. The reaction order (n) was 
determined from the plots of logarithm of the apparent 
inactivation constants versus the logarithm of the con- 
centrations of inactivators (not shown). This allowed the 
determination of values of n close to 1 whatever the 
inactivation reagent with respect o 4-MU glucuronida- 
tion (Table 1). The data indicated the presence of one 
residue critical for enzyme activity. The second order 
inactivation rate constant /(i was evaluated from the 
same representation. This constant value for DCC was 
1200-fold higher than that for EDC (Table 1). The pKa 
of the residue modified by DCC, which reacts with pro- 
tonated residues [15] or by WK reagent, which reacts 
with unprotonated residues [16] were both close to 5.0 
(Fig. 2). Moreover, the simultaneous addition of the ex- 
ogenous nucleophile glycine methyl ester or glycine ethyl 
ester (0-50 mM) with DCC (1.0 mM) did not modify the 
inhibition of UGTI*6 (not shown). A partial inactiva- 
tion of UGTI*6 by DCC did not significantly affect the 
apparent Km toward 4-MU and UDP-GlcU, whereas the 
apparent Vm~ was decreased more than 3-fold under 
these conditions (Table 2). 
3.2. Protection against inactivation by the WK reagent 
The influence of UDP-GIcU and 4-MU on the inacti- 
vation of UGTI*6 was evaluated with the WK reagent 
only, because it reacts with unprotonated carboxyl group 
[16] and thus allowed to perform the experiment at the 
optimal pH (7.4) of 4-MU glucuronidation [11]. We first 
evaluated the possible reactivity of UDP-GlcU with the 
WK reagent since the cofactor possesses a carboxyl 
group which is unprotonated at the optimum pH of the 
glucuronidation reaction [11,17]. For this purpose we 
incubated UDP-GlcU with WK reagent in conditions 
similar to those used for the protection experiment, and 
then submitted the reaction products to HPLC separa- 
tion. The retention time, of UDP-GlcU alone or treated 
by 2 mM WK reagent for 3 min, the relative area of the 
corresponding peaks and the elution profile were identi- 
cal (results not shown). Therefore any possible reactivity 
of the co-substrate with the WK reagent could be ex- 
cluded in the experimental conditions used. Protection 
experiments were performed in the presence of UDP- 
GlcU with the WK reagent at pH 7.4. A partial protec- 
tion against inactivation was observed in the presence of 
UDP-GlcU and, to a lesser extent, in the presence of 
4-MU for concentrations of UDP-GIcU and 4-MU of 
about 10-fold the apparent Km (Fig. 3). Incubation of 
UDP (5.9 mM, 10-fold the apparent Ki) with the mem- 
brane fractions led to a complete protection against inac- 
tivation by the WK reagent (Fig. 3). 
3.3. Influence of  DCC on various recombinant UGTs 
Membrane fractions from recombinant V79 cells ex- 
pressing UGT2B1 [2] and UGTI*02 [9] isoforms were 
treated with DCC and the inhibitory effect of this com- 
pound was compared to that observed with the UGTI*6 
enzyme. Both enzymes were inhibited by DCC, although 
to different extents (Table 3), and the inhibition ranked 
as follows: UGTI*6 > UGTI*02 >> UGT2B1. 
Table 1 
, Kinetic parameters forthe inactivation fUGT1 6 by carboxyl specific 
reagents 
Carboxyl specific reagents 
DCC a EDC a WK reagent b 
n 1.3 0.69 0.97 
kt i  (M -I 'mill -1) 2157 1.8 69.3 
~Inactivation performed atpH 5.0. 
b Inactivation performed atpH 6.0. 
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Fig. 3. Protection of UGTI*6 against inactivation by WK reagent. The 
inactivation was performed in the presence of WK reagent (2 mM) as 
described in Fig. 1 but at pH 7.4. 4-MU (2.5 mM), UDPoGIcU (2.1 
mM) or UDP (5.9 mM) was incubated for 5 min with the membrane 
fractions before addition of WK reagent. (o), WK reagent; (o), WK 
reagent plus 4-MU; (n) WK reagent plus UDP-GlcU; (I) WK reagent 
plus UDP. AM° corresponds to the ratio of the activity in the presence 
of inhibitor, at the time point considered, vs. the initial activity without 
inhibitor. 
4. Discussion 
In this study, three carboxyl-specific reagents (DCC, 
EDC, WK reagent) have been used to demonstrate he 
essential role of a carboxyl group in the catalytic func- 
tion of UGTI*6. Carbodiimide derivatives (DCC, EDC) 
were chosen for their reaction specificity towards pro- 
tonated carboxyl groups of proteins [15], and in order to 
gain insight on the hydrophobicity of the environment 
of the modified residue within the active site of the en- 
zyme. WK reagent was chosen to modify unprotonated 
carboxyl group [16], and thus was convenient toperform 
inactivation experiments in the presence of substrate and 
cofactor at optimum pH of the glucuronidation reaction 
(7.4) [11]. This characterization was supported by several 
conclusive findings. We observed that incubation of 
membrane fractions of V79 ceils expressing UGTI*6 
resulted in a time and concentration dependent inhibi- 
tion of the glucuronidation f 4-MU catalyzed by this 
isoform of UGT. The inactivation order was close to one 
for all the reagents and thus suggests that the decrease 
in activity was dependent on the modification of one 
single essential residue. The second order inactivation 
rate constant for the hydrophobic DCC which was by far 
higher than that measured with the water-soluble r agent 
EDC, likely reflects the presence of a hydrophobic envi- 
ronment around the essential carboxyl group. UGTs are 
membrane-bound enzymes [18-20], and this might also 
be the reason for the lower inactivation rate with EDC, 
when compared to DCC. We have also evaluated the pKa 
of the modified residue, which was close to 5.0, as re- 
vealed from inactivation with DCC or WK reagent as a 
function of pH. This value is in the range of pKa of 
carboxyl groups in proteins. This result is also in accord- 
ance with the VmJKm vs. pH plots previously deter- 
mined [11] which suggests the essential contribution of 
a second unprotonated residue at optimum (pH 7.4), in 
combination with the imidazole group of a histidine res- 
idue. In order to discriminate between the actual involve- 
ment of a carboxyl group in catalysis and a possible 
internal cross-linking, the influence of an exogenous nu- 
cleophile, glycine methyl ester, on the inactivation of 
UGTI*6 by DCC was evaluated. Pedemonte and Kap- 
lan [21] have described the reaction mechanism of the 
modification of carboxyl groups of enzymes with a car- 
bodiimide. A protonated carboxyl group is first modified 
by DCC to give the unstable O-acylurea, which leads 
either to a rearrangement i o a stable N-acylurea group 
or to a reaction with a nucleophile (amino group) result- 
ing in the formation of an amide linkage. In this latter 
case, if the amino group belongs to the enzyme, the 
amide formation results in a cross-linking within the 
active site. It is not possible to distinguish between an 
inhibition due to a modification of the protein conforma- 
tion upon the formation of this cross-linking, or an inhi- 
bition due to the modification of the endogenous nucleo- 
phile responsible for the cross-linking. In this work, the 
lack of effect of increasing concentrations of glycine 
methyl ester or glycine thyl ester on the inactivation of 
UGTI*6 by DCC excluded competition between the ex- 
ogenous nucleophile and a nucleophile of the active site. 
This supports a direct role of a carboxyl group in catal- 
ysis. A protection by UDP-GIcU and, to a lesser extent, 
by 4-MU against inactivation of UGTI*6 by WK rea- 
gent was observed at the optimum pH of the enzyme (pH 
7.4). This result suggests that the essential residue may 
be located within or near the active site. This is also 
supported by the protective ffect exerted by UDP, a 
competitive inhibitor towards UDP-GlcUA binding. 
Moreover, a partial inactivation of the enzyme by DCC 
led to a decrease of the Vm~x without affecting the appar- 
ent Km toward 4-MU and UDP-GlcU, thus suggesting 
that the carboxyl group modified by DCC was not in- 
Table 2 
Kinetic parameters of native and DCC-treated UGTI *6 
UGTI*6 App. Km (mM) App. Vm, ~ 
(nmol/min x mg) 
UDP-GIcU 4-MU 
Native 0.208 0.242 71 
DCC-modified 0.195 0.299 19 
Membrane fractions (1.3 mg protein/ml) were treated with 0.4 mM 
DCC at pH 5.0 and 20°C for 3 min. The kinetic parameters were then 
evaluated in the presence of various UDP-GIcU concentrations (0.05-5 
mM) for a constant concentration of 4-MU (1 mM); and by varying 
the concentration of 4-MU (0.05-1 mM) at a constant concentration 
of 5 mM UDP-GIcU. Apparent Km were determined from the Line- 
weaver-Burk plot of the data. 
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Table 3 
Effect of DCC on various recombinant UGT isoforms tably expressed 
in V79 cells 
DCC (mM) % inactivation 
UGT 1 *6 UGT 1 *02 UGT2B 1 
0.6 a 78.3 + 0.4 53.8 + 0.8 4.3 _+ 0.3 
5.0 a 81.2 _+ 1.0 71.0 + 5.6 6.8 _+ 0.2 
20.0 b 90.3 + 0.1 82.2 + 2.8 28.6 _+ 1.7 
Membrane fractions of recombinant cells (1.3 mg proteirdml) were 
incubated at the indicated concentrations ofDCC at pH 5.0 and 20 ° C. 
The percentage ofinhibition of 4-MU glucuronidation were then eval- 
uated (mean + S.D.). 
The initial values for 4-MU glucuronidation f UGTI*6, UGTI*02 
and UGT2B1 were: 63.4 _+ 5.0; 5.9 + 0.2 and 3.9 + 0.4 (nmol/min x mg 
protein), respectively. 
a Inactivation performed for 5 min. 
a Inactivation performed for 10 min. 
volved in the binding of  these l igands but  in the catalytic 
process [22]. Finally, DCC could inhibit three recombi-  
nant UGTs,  a l though to a different extent, indicating 
that the reactive carboxyl  residue is l ikely conserved 
among the UGT superfamily. The sensitivity of  the glu- 
curonidat ion activity toward  DCC varied depending on 
the isoform considered; UGTI*6  and UGTI*02 ,  which 
belong to the UGT1 family [1] and are from human 
origin were more inhibited by DCC than the rat liver 
UGT2B1 of  the UGT2 family. This could reflect a 
change in the reactivity or  in the accessibil ity of  the 
carboxyl  group, because of  the low sequence homology 
between the two groups of  proteins. 
The involvement of  prototrop ic  groups histidine [11] 
and aspartate or g lutamate supports a general acid/base 
catalysis. These residues are unprotonated at opt imum 
pH (7.4) of  the glucuronidat ion reaction. The base cata- 
lyst, which is l ikely to be involved in the deprotonat ion 
of  aglycones in the catalytic process could be either the 
histidine or the aspartate or g lutamate residue identified 
in this study. A neutral  imidazole group (histidine) could 
however be an acid catalyst a l though the imidazole/imi- 
dazolate pair  is rather unusual  in enzymatic mechanisms 
compared  to the imidazol iurn/ imidazole pair  [23]. The 
second and more l ikely mechanism would involved the 
histidine and the aspartate or g lutamate residues in 
which one of  these residues is the base catalyst while the 
second is orienting and polar iz ing the base catalyst. Such 
a mechanism (charge-relay system) has been proposed 
for the react ion catalysed by DNA gyrase [24] and chy- 
motryps in  [25]. 
Work  is in progress to further identify this residue 
which is involved in the g lucuronidat ion process of  4- 
MU supported by UGTI*6 .  
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